Financial Statements

Sio Gene Therapies Inc. (SIOX)


-0.00 (-1.60%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2022 2021 2020 2019 2018
Retained Earnings (Previous Year) -791--686-557-
Net Income -72-32-73-129-222
Stock Dividends --759759--335
Dividend Paid -----
Retained Earnings -863-791--686-557

PPE Schedule

Year 2022 2021 2020 2019 2018
Gross PPE 2113-
Annual Depreciation 21-0-17
Capital Expenditure -1-0-0-0-4
Net PPE 32113

Intangible and Goodwill Schedule

Year 2022 2021 2020 2019 2018
Intangible and Goodwill (Previous Year) -----
New Purchases -----
Intangible and Goodwill -----

Sio Gene Therapies Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Sio Gene Therapies Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.